RNFT1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.506600E-01 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.069410E-01 |
Normal-vs-Stage2 |
8.272600E-01 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.232600E-01 |
Stage1-vs-Stage2 |
1.022580E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.285800E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.209600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.325200E-01 |
Normal-vs-AfricanAmerican |
1.71049999999617E-05 |
Normal-vs-Asian |
4.621200E-01 |
Caucasian-vs-AfricanAmerican |
1.386770E-04 |
Caucasian-vs-Asian |
7.465000E-01 |
AfricanAmerican-vs-Asian |
5.184700E-03 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.215000E-01 |
Normal-vs-Female |
5.066400E-01 |
Male-vs-Female |
8.626400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.803400E-01 |
Normal-vs-Extreme_Weight |
4.779600E-01 |
Normal-vs-Obese |
2.548400E-01 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.094000E-01 |
Normal_Weight-vs-Obese |
2.609600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.784400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.218400E-01 |
Normal-vs-Age(41-60Yrs) |
4.054600E-01 |
Normal-vs-Age(61-80Yrs) |
3.917000E-01 |
Normal-vs-Age(81-100Yrs) |
3.950200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.757800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.451800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.465000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.633400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.146400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.628400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.232200E-01 |
Normal-vs-Grade 3 |
2.095200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.528200E-01 |
Grade 2-vs-Grade 4 |
5.232200E-01 |
Grade 3-vs-Grade 4 |
2.095200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.126200E-01 |
Normal-vs-N1 |
7.224000E-01 |
N0-vs-N1 |
2.078800E-01 |
|
|